Company Filing History:
Years Active: 2013-2017
Title: Moran Meiron: Innovator in Cell Therapy
Introduction
Moran Meiron is a prominent inventor based in Zikhron-Yaakov, Israel, known for his significant contributions to the field of cell therapy. With a remarkable portfolio consisting of six patents, Meiron has focused on advancing medical treatments through innovative methodologies involving adherent cells derived from placenta and adipose tissue.
Latest Patents
Moran Meiron's latest patents showcase his groundbreaking work in the realm of tissue engineering and medical therapies. His inventions include:
1. A perfusion bioreactor for culturing CD200—placenta adherent cells. This patent discloses a method for culturing adherent cells from placenta or adipose tissue under three-dimensional conditions that facilitate cell expansion through perfusion.
2. A method of utilizing adherent cells from adipose or placenta tissues for therapeutic purposes. This patent describes a method for treating ischemia in patients by administering a therapeutically effective amount of adherent cells derived from either placenta or adipose tissue. Additionally, it outlines a method for addressing medical conditions that require connective tissue regeneration and repair.
Career Highlights
Moran Meiron is currently associated with Pluristem Ltd., a respected company in the field of regenerative medicine. His work is highly regarded for its potential to transform therapeutic approaches to various medical conditions, particularly those related to tissue repair and regeneration.
Collaborations
Throughout his career, Moran has collaborated with notable colleagues, including Amir Toren and Nirit Drori-Carmi. These partnerships have fostered an environment of innovation and creativity, contributing to the successful development of his patents and their applications in modern medicine.
Conclusion
Moran Meiron exemplifies the spirit of innovation in medical science through his dedicated work on patents that bridge the gap between cell culture techniques and practical therapeutic applications. His contributions not only highlight the potential of cells from placenta and adipose tissues but also pave the way for future advancements in regenerative therapies.